Document is current
Any future updates will be listed below
-
Authors
van Pelt, Jos http://orcid.org/0000-0001-6903-4338
Meeusen, Bob
Derua, Rita
Guffens, Liesbeth
Van Cutsem, Eric
Janssens, Veerle
Verslype, Chris
- License Information
-
More Information
Article History
Received: 19 February 2023
Accepted: 20 April 2023
First Online: 11 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: Prof. Dr. Eric Van Cutsem reports grants from Bayer. Boehringer Ingelheim. Celgene. Ipsen. Lilly. Merck. Merck KgA. Novartis. Roche. and Servier. and has served on advisory boards for Array. AstraZeneca. Bayer. Biocartis. Bristol Myers Squib. Celgene. Daiichi. Halozyme. GSK. Incyte. Ipsen. Lilly. Merck. Merck KgA. Novartis. Roche. and Servier, all outside the sub-mitted work. Prof. Dr. Chris Verslype reports grants from Ipsen. Bayer and Novartis. All authors declare no potential conflicts of interest in this work.
